Black Fungus Drug Policy: HC Tells Centre to Save Younger People

The Delhi High Court on Tuesday asked the Centre to frame a policy on the distribution of Liposomal Amphotericin B, a drug used in the treatment of black fungus. It added that younger people and those with better chances of survival should be prioritised, instead of older ones who have lived a full life.

A Division Bench of Justices Vipin Sanghi and Jasmeet Singh asked the Centre to frame the policy and file a status report in this regard and listed the matter for Friday. The court asked the Centre to take a policy decision on the manner the medicine Amphotericin B drug, used for treating black fungus, should be made available to patients, making it clear that any decision taken in this regard should be with inputs from medical professionals.

The court also suggested patients should be prioritised — who have a better chance to survive so at least some lives can be saved.

The High Court said that those who have a better chance of survival, who are younger and hold the promise of the future have to be prioritised over the older generation who have lived their lives.

The Court, however, clarified by saying that, “We are not for a moment discounting the emotional support that the older generation provides families, particularly Indian families that are so closely bonded.”

The Court said that difficult choices have to be made and should be made at this stage.

“If we have to choose, the young will have to be chosen. They are the future. 80-year olds are not going to carry this country forward. They have lived their lives,” the Court said.

“We may also observe that there may be a category of persons who are serving the nation at high positions and whose safety and security may have to be kept in mind due to the pivotal role that they play; the policy may provide for such cases,” it added.

The Court noted the number of cases of black fungus is increasing day-by-day and a large number of fatalities are taking place. Despite best efforts, the country is suffering from a shortage of the drug in the country.

It also noted that the requirement of Liposomal Amphotericin B is far in excess.

The Court was hearing a batch of pleas on COVID-19 and black fungus management in the national capital.

Recent Posts

  • Featured

NHRC Notice To Assam Police Over Assault On Journalist In Lumding

The National Human Rights Commission (NHRC) has taken suo motu cognisance of a disturbing incident involving the assault of a…

4 hours ago
  • Featured

India’s Urban-Rural Air Quality Divide

New research comparing 141 cities across India reveals that seasonal climate and geography lead to contrasting regional signatures of aerosol…

9 hours ago
  • Featured

How Hardships & Hashtags Combined To Fuel Nepal Violence

Days of unrest in Nepal have resulted in the ousting of a deeply unpopular government and the deaths of at…

11 hours ago
  • Featured

A New World Order Is Here And This Is What It Looks Like

On Sept. 3, 2025, China celebrated the 80th anniversary of its victory over Japan by staging a carefully choreographed event…

3 days ago
  • Featured

11 Yrs After Fatal Floods, Kashmir Is Hit Again And Remains Unprepared

Since August 20, Jammu and Kashmir has been lashed by intermittent rainfall. Flash floods and landslides in the Jammu region…

3 days ago
  • Featured

A Beloved ‘Tree Of Life’ Is Vanishing From An Already Scarce Desert

The social, economic and cultural importance of the khejri tree in the Thar desert has earned it the title of…

3 days ago

This website uses cookies.